Evolution of neurosurgical advances and nuances in medulloblastoma therapy

go back to reference Ostrom QT, Price M, Ryan K, Edelson J, Neff C, Cioffi G, Waite KA, Kruchko C, Barnholtz-Sloan JS (2022) CBTRUS statistical report: pediatric brain tumor foundation childhood and adolescent primary brain and other central nervous system tumors diagnosed in the United States in 2014–2018. Neuro Oncol 24:iii1–iii38. https://doi.org/10.1093/neuonc/noac161 Ostrom QT, Price M, Ryan K, Edelson J, Neff C, Cioffi G, Waite KA, Kruchko C, Barnholtz-Sloan JS (2022) CBTRUS statistical report: pediatric brain tumor foundation childhood and adolescent primary brain and other central nervous system tumors diagnosed in the United States in 2014–2018. Neuro Oncol 24:iii1–iii38. https://​doi.​org/​10.​1093/​neuonc/​noac161

go back to reference Smoll NR, Drummond KJ (2012) The incidence of medulloblastomas and primitive neurectodermal tumours in adults and children. J Clin Neurosci 19:1541–1544. https://doi.org/10.1016/j.jocn.2012.04.009CrossRefPubMed Smoll NR, Drummond KJ (2012) The incidence of medulloblastomas and primitive neurectodermal tumours in adults and children. J Clin Neurosci 19:1541–1544. https://​doi.​org/​10.​1016/​j.​jocn.​2012.​04.​009CrossRefPubMed

go back to reference Ostrom QT, de Blank PM, Kruchko C, Petersen CM, Liao P, Finlay JL, Stearns DS, Wolff JE, Wolinsky Y, Letterio JJ, Barnholtz-Sloan JS (2015) Alex’s Lemonade Stand Foundation infant and childhood primary brain and central nervous system tumors diagnosed in the United States in 2007–2011. Neuro Oncol 16(Suppl 10):x1–x36. https://doi.org/10.1093/neuonc/nou327CrossRefPubMed Ostrom QT, de Blank PM, Kruchko C, Petersen CM, Liao P, Finlay JL, Stearns DS, Wolff JE, Wolinsky Y, Letterio JJ, Barnholtz-Sloan JS (2015) Alex’s Lemonade Stand Foundation infant and childhood primary brain and central nervous system tumors diagnosed in the United States in 2007–2011. Neuro Oncol 16(Suppl 10):x1–x36. https://​doi.​org/​10.​1093/​neuonc/​nou327CrossRefPubMed

go back to reference Ostrom QT, Cioffi G, Waite K, Kruchko C, Barnholtz-Sloan JS (2021) CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2014–2018. Neuro Oncol 23:iii1–iii105. https://doi.org/10.1093/neuonc/noab200 Ostrom QT, Cioffi G, Waite K, Kruchko C, Barnholtz-Sloan JS (2021) CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2014–2018. Neuro Oncol 23:iii1–iii105. https://​doi.​org/​10.​1093/​neuonc/​noab200

go back to reference Muskens IS, Feng Q, Francis SS, Walsh KM, McKean-Cowdin R, Gauderman WJ, de Smith AJ, Wiemels JL (2020) Pediatric glioma and medulloblastoma risk and population demographics: a Poisson regression analysis. Neurooncol Adv 2:vdaa089. https://doi.org/10.1093/noajnl/vdaa089 Muskens IS, Feng Q, Francis SS, Walsh KM, McKean-Cowdin R, Gauderman WJ, de Smith AJ, Wiemels JL (2020) Pediatric glioma and medulloblastoma risk and population demographics: a Poisson regression analysis. Neurooncol Adv 2:vdaa089. https://​doi.​org/​10.​1093/​noajnl/​vdaa089

go back to reference Northcott PA, Robinson GW, Kratz CP, Mabbott DJ, Pomeroy SL, Clifford SC, Rutkowski S, Ellison DW, Malkin D, Taylor MD, Gajjar A, Pfister SM (2019) Medulloblastoma Nat Rev Dis Primers 5:11. https://doi.org/10.1038/s41572-019-0063-6CrossRefPubMed Northcott PA, Robinson GW, Kratz CP, Mabbott DJ, Pomeroy SL, Clifford SC, Rutkowski S, Ellison DW, Malkin D, Taylor MD, Gajjar A, Pfister SM (2019) Medulloblastoma Nat Rev Dis Primers 5:11. https://​doi.​org/​10.​1038/​s41572-019-0063-6CrossRefPubMed

go back to reference Vinchon M, Leblond P (2021) Medulloblastoma: clinical presentation. Neurochirurgie 67:23–27. https://doi.org/10.1016/j.neuchi.2019.04.006CrossRefPubMed Vinchon M, Leblond P (2021) Medulloblastoma: clinical presentation. Neurochirurgie 67:23–27. https://​doi.​org/​10.​1016/​j.​neuchi.​2019.​04.​006CrossRefPubMed

go back to reference Ramaswamy V, Remke M, Shih D, Wang X, Northcott PA, Faria CC, Raybaud C, Tabori U, Hawkins C, Rutka J, Taylor MD, Bouffet E (2014) Duration of the pre-diagnostic interval in medulloblastoma is subgroup dependent. Pediatr Blood Cancer 61:1190–1194. https://doi.org/10.1002/pbc.25002CrossRefPubMed Ramaswamy V, Remke M, Shih D, Wang X, Northcott PA, Faria CC, Raybaud C, Tabori U, Hawkins C, Rutka J, Taylor MD, Bouffet E (2014) Duration of the pre-diagnostic interval in medulloblastoma is subgroup dependent. Pediatr Blood Cancer 61:1190–1194. https://​doi.​org/​10.​1002/​pbc.​25002CrossRefPubMed

go back to reference Srinivasan VM, Ghali MG, North RY, Boghani Z, Hansen D, Lam S (2016) Modern management of medulloblastoma: Molecular classification, outcomes, and the role of surgery. Surg Neurol Int 7:S1135-s1141. https://doi.org/10.4103/2152-7806.196922CrossRefPubMedPubMedCentral Srinivasan VM, Ghali MG, North RY, Boghani Z, Hansen D, Lam S (2016) Modern management of medulloblastoma: Molecular classification, outcomes, and the role of surgery. Surg Neurol Int 7:S1135-s1141. https://​doi.​org/​10.​4103/​2152-7806.​196922CrossRefPubMedPubMedCentral

go back to reference Taylor RE, Bailey CC, Robinson KJ, Weston CL, Walker DA, Ellison D, Ironside J, Pizer BL, Lashford LS (2005) Outcome for patients with metastatic (M2–3) medulloblastoma treated with SIOP/UKCCSG PNET-3 chemotherapy. Eur J Cancer 41:727–734. https://doi.org/10.1016/j.ejca.2004.12.017CrossRefPubMed Taylor RE, Bailey CC, Robinson KJ, Weston CL, Walker DA, Ellison D, Ironside J, Pizer BL, Lashford LS (2005) Outcome for patients with metastatic (M2–3) medulloblastoma treated with SIOP/UKCCSG PNET-3 chemotherapy. Eur J Cancer 41:727–734. https://​doi.​org/​10.​1016/​j.​ejca.​2004.​12.​017CrossRefPubMed

go back to reference Dufour C, Beaugrand A, Pizer B, Micheli J, Aubelle MS, Fourcade A, Couanet D, Laplanche A, Kalifa C, Grill J (2012) Metastatic medulloblastoma in childhood: Chang’s classification revisited. Int J Surg Oncol 2012:245385. https://doi.org/10.1155/2012/245385CrossRefPubMed Dufour C, Beaugrand A, Pizer B, Micheli J, Aubelle MS, Fourcade A, Couanet D, Laplanche A, Kalifa C, Grill J (2012) Metastatic medulloblastoma in childhood: Chang’s classification revisited. Int J Surg Oncol 2012:245385. https://​doi.​org/​10.​1155/​2012/​245385CrossRefPubMed

go back to reference Cotter JA, Hawkins C (2022) Medulloblastoma: WHO 2021 and beyond. Pediatr Dev Pathol 25:23–33. https://doi.org/10.1177/10935266211018931CrossRefPubMed Cotter JA, Hawkins C (2022) Medulloblastoma: WHO 2021 and beyond. Pediatr Dev Pathol 25:23–33. https://​doi.​org/​10.​1177/​1093526621101893​1CrossRefPubMed

go back to reference Ellison DW, Dalton J, Kocak M, Nicholson SL, Fraga C, Neale G, Kenney AM, Brat DJ, Perry A, Yong WH, Taylor RE, Bailey S, Clifford SC, Gilbertson RJ (2011) Medulloblastoma: clinicopathological correlates of SHH, WNT, and non-SHH/WNT molecular subgroups. Acta Neuropathol 121:381–396. https://doi.org/10.1007/s00401-011-0800-8CrossRefPubMedPubMedCentral Ellison DW, Dalton J, Kocak M, Nicholson SL, Fraga C, Neale G, Kenney AM, Brat DJ, Perry A, Yong WH, Taylor RE, Bailey S, Clifford SC, Gilbertson RJ (2011) Medulloblastoma: clinicopathological correlates of SHH, WNT, and non-SHH/WNT molecular subgroups. Acta Neuropathol 121:381–396. https://​doi.​org/​10.​1007/​s00401-011-0800-8CrossRefPubMedPubMedCentral

go back to reference de Haas T, Oussoren E, Grajkowska W, Perek-Polnik M, Popovic M, Zadravec-Zaletel L, Perera M, Corte G, Wirths O, van Sluis P, Pietsch T, Troost D, Baas F, Versteeg R, Kool M (2006) OTX1 and OTX2 expression correlates with the clinicopathologic classification of medulloblastomas. J Neuropathol Exp Neurol 65:176–186. https://doi.org/10.1097/01.jnen.0000199576.70923.8aCrossRefPubMed de Haas T, Oussoren E, Grajkowska W, Perek-Polnik M, Popovic M, Zadravec-Zaletel L, Perera M, Corte G, Wirths O, van Sluis P, Pietsch T, Troost D, Baas F, Versteeg R, Kool M (2006) OTX1 and OTX2 expression correlates with the clinicopathologic classification of medulloblastomas. J Neuropathol Exp Neurol 65:176–186. https://​doi.​org/​10.​1097/​01.​jnen.​0000199576.​70923.​8aCrossRefPubMed

go back to reference Choi JY (2023) Medulloblastoma: current perspectives and recent advances. Brain Tumor Res Treat 11:28–38. https://doi.org/10.14791/btrt.2022.0046CrossRefPubMedPubMedCentral Choi JY (2023) Medulloblastoma: current perspectives and recent advances. Brain Tumor Res Treat 11:28–38. https://​doi.​org/​10.​14791/​btrt.​2022.​0046CrossRefPubMedPubMedCentral

go back to reference Mulhern RK, Palmer SL, Merchant TE, Wallace D, Kocak M, Brouwers P, Krull K, Chintagumpala M, Stargatt R, Ashley DM, Tyc VL, Kun L, Boyett J, Gajjar A (2005) Neurocognitive consequences of risk-adapted therapy for childhood medulloblastoma. J Clin Oncol 23:5511–5519. https://doi.org/10.1200/jco.2005.00.703CrossRefPubMed Mulhern RK, Palmer SL, Merchant TE, Wallace D, Kocak M, Brouwers P, Krull K, Chintagumpala M, Stargatt R, Ashley DM, Tyc VL, Kun L, Boyett J, Gajjar A (2005) Neurocognitive consequences of risk-adapted therapy for childhood medulloblastoma. J Clin Oncol 23:5511–5519. https://​doi.​org/​10.​1200/​jco.​2005.​00.​703CrossRefPubMed

go back to reference Mabbott DJ, Penkman L, Witol A, Strother D, Bouffet E (2008) Core neurocognitive functions in children treated for posterior fossa tumors. Neuropsychology 22:159–168. https://doi.org/10.1037/0894-4105.22.2.159CrossRefPubMed Mabbott DJ, Penkman L, Witol A, Strother D, Bouffet E (2008) Core neurocognitive functions in children treated for posterior fossa tumors. Neuropsychology 22:159–168. https://​doi.​org/​10.​1037/​0894-4105.​22.​2.​159CrossRefPubMed

go back to reference Gudrunardottir T, Lannering B, Remke M, Taylor MD, Wells EM, Keating RF, Packer RJ (2014) Treatment developments and the unfolding of the quality of life discussion in childhood medulloblastoma: a review. Childs Nerv Syst 30:979–990. https://doi.org/10.1007/s00381-014-2388-5CrossRefPubMed Gudrunardottir T, Lannering B, Remke M, Taylor MD, Wells EM, Keating RF, Packer RJ (2014) Treatment developments and the unfolding of the quality of life discussion in childhood medulloblastoma: a review. Childs Nerv Syst 30:979–990. https://​doi.​org/​10.​1007/​s00381-014-2388-5CrossRefPubMed

go back to reference King AA, Seidel K, Di C, Leisenring WM, Perkins SM, Krull KR, Sklar CA, Green DM, Armstrong GT, Zeltzer LK, Wells E, Stovall M, Ullrich NJ, Oeffinger KC, Robison LL, Packer RJ (2017) Long-term neurologic health and psychosocial function of adult survivors of childhood medulloblastoma/PNET: a report from the Childhood Cancer Survivor Study. Neuro Oncol 19:689–698. https://doi.org/10.1093/neuonc/now242CrossRefPubMed King AA, Seidel K, Di C, Leisenring WM, Perkins SM, Krull KR, Sklar CA, Green DM, Armstrong GT, Zeltzer LK, Wells E, Stovall M, Ullrich NJ, Oeffinger KC, Robison LL, Packer RJ (2017) Long-term neurologic health and psychosocial function of adult survivors of childhood medulloblastoma/PNET: a report from the Childhood Cancer Survivor Study. Neuro Oncol 19:689–698. https://​doi.​org/​10.​1093/​neuonc/​now242CrossRefPubMed

go back to reference Salloum R, Chen Y, Yasui Y, Packer R, Leisenring W, Wells E, King A, Howell R, Gibson TM, Krull KR, Robison LL, Oeffinger KC, Fouladi M, Armstrong GT (2019) Late morbidity and mortality among medulloblastoma survivors diagnosed across three decades: a report from the childhood cancer survivor study. J Clin Oncol 37:731–740. https://doi.org/10.1200/jco.18.00969CrossRefPubMedPubMedCentral Salloum R, Chen Y, Yasui Y, Packer R, Leisenring W, Wells E, King A, Howell R, Gibson TM, Krull KR, Robison LL, Oeffinger KC, Fouladi M, Armstrong GT (2019) Late morbidity and mortality among medulloblastoma survivors diagnosed across three decades: a report from the childhood cancer survivor study. J Clin Oncol 37:731–740. https://​doi.​org/​10.​1200/​jco.​18.​00969CrossRefPubMedPubMedCentral

go back to reference Olivier TW, Bass JK, Ashford JM, Beaulieu R, Scott SM, Schreiber JE, Palmer S, Mabbott DJ, Swain MA, Bonner M, Boyle R, Chapeiski ML, Evankovich KD, Armstrong CL, Knight SJ, Wu S, Onar-Thomas A, Gajjar A, Conklin HM (2019) Cognitive implications of ototoxicity in pediatric patients with embryonal brain tumors. J Clin Oncol 37:1566–1575. https://doi.org/10.1200/jco.18.01358CrossRefPubMedPubMedCentral Olivier TW, Bass JK, Ashford JM, Beaulieu R, Scott SM, Schreiber JE, Palmer S, Mabbott DJ, Swain MA, Bonner M, Boyle R, Chapeiski ML, Evankovich KD, Armstrong CL, Knight SJ, Wu S, Onar-Thomas A, Gajjar A, Conklin HM (2019) Cognitive implications of ototoxicity in pediatric patients with embryonal brain tumors. J Clin Oncol 37:1566–1575. https://​doi.​org/​10.​1200/​jco.​18.​01358CrossRefPubMedPubMedCentral

go back to reference Cavalli FMG, Remke M, Rampasek L, Peacock J, Shih DJH, Luu B, Garzia L, Torchia J, Nor C, Morrissy AS, Agnihotri S, Thompson YY, Kuzan-Fischer CM, Farooq H, Isaev K, Daniels C, Cho BK, Kim SK, Wang KC, Lee JY, Grajkowska WA, Perek-Polnik M, Vasiljevic A, Faure-Conter C, Jouvet A, Giannini C, Nageswara Rao AA, Li KKW, Ng HK, Eberhart CG, Pollack IF, Hamilton RL, Gillespie GY, Olson JM, Leary S, Weiss WA, Lach B, Chambless LB, Thompson RC, Cooper MK, Vibhakar R, Hauser P, van Veelen MC, Kros JM, French PJ, Ra YS, Kumabe T, López-Aguilar E, Zitterbart K, Sterba J, Finocchiaro G, Massimino M, Van Meir EG, Osuka S, Shofuda T, Klekner A, Zollo M, Leonard JR, Rubin JB, Jabado N, Albrecht S, Mora J, Van Meter TE, Jung S, Moore AS, Hallahan AR, Chan JA, Tirapelli DPC, Carlotti CG, Fouladi M, Pimentel J, Faria CC, Saad AG, Massimi L, Liau LM, Wheeler H, Nakamura H, Elbabaa SK, Perezpeña-Diazconti M, Ponce C, de León F, Robinson S, Zapotocky M, Lassaletta A, Huang A, Hawkins CE, Tabori U, Bouffet E, Bartels U, Dirks PB, Rutka JT, Bader GD, Reimand J, Goldenberg A, Ramaswamy V, Taylor MD (2017) Intertumoral heterogeneity within medulloblastoma subgroups. Cancer Cell 31:737-754.e736. https://doi.org/10.1016/j.ccell.2017.05.005CrossRefPubMedPubMedCentral Cavalli FMG, Remke M, Rampasek L, Peacock J, Shih DJH, Luu B, Garzia L, Torchia J, Nor C, Morrissy AS, Agnihotri S, Thompson YY, Kuzan-Fischer CM, Farooq H, Isaev K, Daniels C, Cho BK, Kim SK, Wang KC, Lee JY, Grajkowska WA, Perek-Polnik M, Vasiljevic A, Faure-Conter C, Jouvet A, Giannini C, Nageswara Rao AA, Li KKW, Ng HK, Eberhart CG, Pollack IF, Hamilton RL, Gillespie GY, Olson JM, Leary S, Weiss WA, Lach B, Chambless LB, Thompson RC, Cooper MK, Vibhakar R, Hauser P, van Veelen MC, Kros JM, French PJ, Ra YS, Kumabe T, López-Aguilar E, Zitterbart K, Sterba J, Finocchiaro G, Massimino M, Van Meir EG, Osuka S, Shofuda T, Klekner A, Zollo M, Leonard JR, Rubin JB, Jabado N, Albrecht S, Mora J, Van Meter TE, Jung S, Moore AS, Hallahan AR, Chan JA, Tirapelli DPC, Carlotti CG, Fouladi M, Pimentel J, Faria CC, Saad AG, Massimi L, Liau LM, Wheeler H, Nakamura H, Elbabaa SK, Perezpeña-Diazconti M, Ponce C, de León F, Robinson S, Zapotocky M, Lassaletta A, Huang A, Hawkins CE, Tabori U, Bouffet E, Bartels U, Dirks PB, Rutka JT, Bader GD, Reimand J, Goldenberg A, Ramaswamy V, Taylor MD (2017) Intertumoral heterogeneity within medulloblastoma subgroups. Cancer Cell 31:737-754.e736. https://​doi.​org/​10.​1016/​j.​ccell.​2017.​05.​005CrossRefPubMedPubMedCentral

go back to reference Sharma T, Schwalbe EC, Williamson D, Sill M, Hovestadt V, Mynarek M, Rutkowski S, Robinson GW, Gajjar A, Cavalli F, Ramaswamy V, Taylor MD, Lindsey JC, Hill RM, Jäger N, Korshunov A, Hicks D, Bailey S, Kool M, Chavez L, Northcott PA, Pfister SM, Clifford SC (2019) Second-generation molecular subgrouping of medulloblastoma: an international meta-analysis of Group 3 and Group 4 subtypes. Acta Neuropathol 138:309–326. https://doi.org/10.1007/s00401-019-02020-0CrossRefPubMedPubMedCentral Sharma T, Schwalbe EC, Williamson D, Sill M, Hovestadt V, Mynarek M, Rutkowski S, Robinson GW, Gajjar A, Cavalli F, Ramaswamy V, Taylor MD, Lindsey JC, Hill RM, Jäger N, Korshunov A, Hicks D, Bailey S, Kool M, Chavez L, Northcott PA, Pfister SM, Clifford SC (2019) Second-generation molecular subgrouping of medulloblastoma: an international meta-analysis of Group 3 and Group 4 subtypes. Acta Neuropathol 138:309–326. https://​doi.​org/​10.​1007/​s00401-019-02020-0CrossRefPubMedPubMedCentral

go back to reference Louis DN, Perry A, Wesseling P, Brat DJ, Cree IA, Figarella-Branger D, Hawkins C, Ng HK, Pfister SM, Reifenberger G, Soffietti R, von Deimling A, Ellison DW (2021) The 2021 WHO classification of tumors of the central nervous system: a summary. Neuro Oncol 23:1231–1251. https://doi.org/10.1093/neuonc/noab106CrossRefPubMedPubMedCentral Louis DN, Perry A, Wesseling P, Brat DJ, Cree IA, Figarella-Branger D, Hawkins C, Ng HK, Pfister SM, Reifenberger G, Soffietti R, von Deimling A, Ellison DW (2021) The 2021 WHO classification of tumors of the central nervous system: a summary. Neuro Oncol 23:1231–1251. https://​doi.​org/​10.​1093/​neuonc/​noab106CrossRefPubMedPubMedCentral

go back to reference Ramaswamy V, Remke M, Bouffet E, Bailey S, Clifford SC, Doz F, Kool M, Dufour C, Vassal G, Milde T, Witt O, von Hoff K, Pietsch T, Northcott PA, Gajjar A, Robinson GW, Padovani L, André N, Massimino M, Pizer B, Packer R, Rutkowski S, Pfister SM, Taylor MD, Pomeroy SL (2016) Risk stratification of childhood medulloblastoma in the molecular era: the current consensus. Acta Neuropathol 131:821–831. https://doi.org/10.1007/s00401-016-1569-6CrossRefPubMedPubMedCentral Ramaswamy V, Remke M, Bouffet E, Bailey S, Clifford SC, Doz F, Kool M, Dufour C, Vassal G, Milde T, Witt O, von Hoff K, Pietsch T, Northcott PA, Gajjar A, Robinson GW, Padovani L, André N, Massimino M, Pizer B, Packer R, Rutkowski S, Pfister SM, Taylor MD, Pomeroy SL (2016) Risk stratification of childhood medulloblastoma in the molecular era: the current consensus. Acta Neuropathol 131:821–831. https://​doi.​org/​10.​1007/​s00401-016-1569-6CrossRefPubMedPubMedCentral

go back to reference Chang CH, Housepian EM, Herbert C Jr (1969) An operative staging system and a megavoltage radiotherapeutic technic for cerebellar medulloblastomas. Radiology 93:1351–1359. https://doi.org/10.1148/93.6.1351CrossRefPubMed Chang CH, Housepian EM, Herbert C Jr (1969) An operative staging system and a megavoltage radiotherapeutic technic for cerebellar medulloblastomas. Radiology 93:1351–1359. https://​doi.​org/​10.​1148/​93.​6.​1351CrossRefPubMed

go back to reference Gajjar A, Chintagumpala M, Ashley D, Kellie S, Kun LE, Merchant TE, Woo S, Wheeler G, Ahern V, Krasin MJ, Fouladi M, Broniscer A, Krance R, Hale GA, Stewart CF, Dauser R, Sanford RA, Fuller C, Lau C, Boyett JM, Wallace D, Gilbertson RJ (2006) Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trial. Lancet Oncol 7:813–820. https://doi.org/10.1016/s1470-2045(06)70867-1CrossRefPubMed Gajjar A, Chintagumpala M, Ashley D, Kellie S, Kun LE, Merchant TE, Woo S, Wheeler G, Ahern V, Krasin MJ, Fouladi M, Broniscer A, Krance R, Hale GA, Stewart CF, Dauser R, Sanford RA, Fuller C, Lau C, Boyett JM, Wallace D, Gilbertson RJ (2006) Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trial. Lancet Oncol 7:813–820. https://​doi.​org/​10.​1016/​s1470-2045(06)70867-1CrossRefPubMed

go back to reference Gandola L, Massimino M, Cefalo G, Solero C, Spreafico F, Pecori E, Riva D, Collini P, Pignoli E, Giangaspero F, Luksch R, Berretta S, Poggi G, Biassoni V, Ferrari A, Pollo B, Favre C, Sardi I, Terenziani M, Fossati-Bellani F (2009) Hyperfractionated accelerated radiotherapy in the Milan strategy for metastatic medulloblastoma. J Clin Oncol 27:566–571. https://doi.org/10.1200/jco.2008.18.4176CrossRefPubMed Gandola L, Massimino M, Cefalo G, Solero C, Spreafico F, Pecori E, Riva D, Collini P, Pignoli E, Giangaspero F, Luksch R, Berretta S, Poggi G, Biassoni V, Ferrari A, Pollo B, Favre C, Sardi I, Terenziani M, Fossati-Bellani F (2009) Hyperfractionated accelerated radiotherapy in the Milan strategy for metastatic medulloblastoma. J Clin Oncol 27:566–571. https://​doi.​org/​10.​1200/​jco.​2008.​18.​4176CrossRefPubMed

go back to reference Jakacki RI, Burger PC, Zhou T, Holmes EJ, Kocak M, Onar A, Goldwein J, Mehta M, Packer RJ, Tarbell N, Fitz C, Vezina G, Hilden J, Pollack IF (2012) Outcome of children with metastatic medulloblastoma treated with carboplatin during craniospinal radiotherapy: a Children’s Oncology Group Phase I/II study. J Clin Oncol 30:2648–2653. https://doi.org/10.1200/jco.2011.40.2792CrossRefPubMedPubMedCentral Jakacki RI, Burger PC, Zhou T, Holmes EJ, Kocak M, Onar A, Goldwein J, Mehta M, Packer RJ, Tarbell N, Fitz C, Vezina G, Hilden J, Pollack IF (2012) Outcome of children with metastatic medulloblastoma treated with carboplatin during craniospinal radiotherapy: a Children’s Oncology Group Phase I/II study. J Clin Oncol 30:2648–2653. https://​doi.​org/​10.​1200/​jco.​2011.​40.​2792CrossRefPubMedPubMedCentral

go back to reference Packer RJ, Gajjar A, Vezina G, Rorke-Adams L, Burger PC, Robertson PL, Bayer L, LaFond D, Donahue BR, Marymont MH, Muraszko K, Langston J, Sposto R (2006) Phase III study of craniospinal radiation therapy followed by adjuvant chemotherapy for newly diagnosed average-risk medulloblastoma. J Clin Oncol 24:4202–4208. https://doi.org/10.1200/jco.2006.06.4980CrossRefPubMed Packer RJ, Gajjar A, Vezina G, Rorke-Adams L, Burger PC, Robertson PL, Bayer L, LaFond D, Donahue BR, Marymont MH, Muraszko K, Langston J, Sposto R (2006) Phase III study of craniospinal radiation therapy followed by adjuvant chemotherapy for newly diagnosed average-risk medulloblastoma. J Clin Oncol 24:4202–4208. https://​doi.​org/​10.​1200/​jco.​2006.​06.​4980CrossRefPubMed

go back to reference Oyharcabal-Bourden V, Kalifa C, Gentet JC, Frappaz D, Edan C, Chastagner P, Sariban E, Pagnier A, Babin A, Pichon F, Neuenschwander S, Vinchon M, Bours D, Mosseri V, Le Gales C, Ruchoux M, Carrie C, Doz F (2005) Standard-risk medulloblastoma treated by adjuvant chemotherapy followed by reduced-dose craniospinal radiation therapy: a French Society of Pediatric Oncology Study. J Clin Oncol 23:4726–4734. https://doi.org/10.1200/jco.2005.00.760CrossRefPubMed Oyharcabal-Bourden V, Kalifa C, Gentet JC, Frappaz D, Edan C, Chastagner P, Sariban E, Pagnier A, Babin A, Pichon F, Neuenschwander S, Vinchon M, Bours D, Mosseri V, Le Gales C, Ruchoux M, Carrie C, Doz F (2005) Standard-risk medulloblastoma treated by adjuvant chemotherapy followed by reduced-dose craniospinal radiation therapy: a French Society of Pediatric Oncology Study. J Clin Oncol 23:4726–4734. https://​doi.​org/​10.​1200/​jco.​2005.​00.​760CrossRefPubMed

go back to reference Orr BA (2020) Pathology, diagnostics, and classification of medulloblastoma. Brain Pathol 30:664–678. https://doi.org/10.1111/bpa.12837CrossRefPubMedPubMedCentral Orr BA (2020) Pathology, diagnostics, and classification of medulloblastoma. Brain Pathol 30:664–678. https://​doi.​org/​10.​1111/​bpa.​12837CrossRefPubMedPubMedCentral

go back to reference Thompson EM, Hielscher T, Bouffet E, Remke M, Luu B, Gururangan S, McLendon RE, Bigner DD, Lipp ES, Perreault S, Cho YJ, Grant G, Kim SK, Lee JY, Rao AAN, Giannini C, Li KKW, Ng HK, Yao Y, Kumabe T, Tominaga T, Grajkowska WA, Perek-Polnik M, Low DCY, Seow WT, Chang KTE, Mora J, Pollack IF, Hamilton RL, Leary S, Moore AS, Ingram WJ, Hallahan AR, Jouvet A, Fèvre-Montange M, Vasiljevic A, Faure-Conter C, Shofuda T, Kagawa N, Hashimoto N, Jabado N, Weil AG, Gayden T, Wataya T, Shalaby T, Grotzer M, Zitterbart K, Sterba J, Kren L, Hortobágyi T, Klekner A, László B, Pócza T, Hauser P, Schüller U, Jung S, Jang WY, French PJ, Kros JM, van Veelen MC, Massimi L, Leonard JR, Rubin JB, Vibhakar R, Chambless LB, Cooper MK, Thompson RC, Faria CC, Carvalho A, Nunes S, Pimentel J, Fan X, Muraszko KM, López-Aguilar E, Lyden D, Garzia L, Shih DJH, Kijima N, Schneider C, Adamski J, Northcott PA, Kool M, Jones DTW, Chan JA, Nikolic A, Garre ML, Van Meir EG, Osuka S, Olson JJ, Jahangiri A, Castro BA, Gupta N, Weiss WA, Moxon-Emre I, Mabbott DJ, Lassaletta A, Hawkins CE, Tabori U, Drake J, Kulkarni A, Dirks P, Rutka JT, Korshunov A, Pfister SM, Packer RJ, Ramaswamy V, Taylor MD (2016) Prognostic value of medulloblastoma extent of resection after accounting for molecular subgroup: a retrospective integrated clinical and molecular analysis. Lancet Oncol 17:484–495. https://doi.org/10.1016/s1470-2045(15)00581-1CrossRefPubMedPubMedCentral Thompson EM, Hielscher T, Bouffet E, Remke M, Luu B, Gururangan S, McLendon RE, Bigner DD, Lipp ES, Perreault S, Cho YJ, Grant G, Kim SK, Lee JY, Rao AAN, Giannini C, Li KKW, Ng HK, Yao Y, Kumabe T, Tominaga T, Grajkowska WA, Perek-Polnik M, Low DCY, Seow WT, Chang KTE, Mora J, Pollack IF, Hamilton RL, Leary S, Moore AS, Ingram WJ, Hallahan AR, Jouvet A, Fèvre-Montange M, Vasiljevic A, Faure-Conter C, Shofuda T, Kagawa N, Hashimoto N, Jabado N, Weil AG, Gayden T, Wataya T, Shalaby T, Grotzer M, Zitterbart K, Sterba J, Kren L, Hortobágyi T, Klekner A, László B, Pócza T, Hauser P, Schüller U, Jung S, Jang WY, French PJ, Kros JM, van Veelen MC, Massimi L, Leonard JR, Rubin JB, Vibhakar R, Chambless LB, Cooper MK, Thompson RC, Faria CC, Carvalho A, Nunes S, Pimentel J, Fan X, Muraszko KM, López-Aguilar E, Lyden D, Garzia L, Shih DJH, Kijima N, Schneider C, Adamski J, Northcott PA, Kool M, Jones DTW, Chan JA, Nikolic A, Garre ML, Van Meir EG, Osuka S, Olson JJ, Jahangiri A, Castro BA, Gupta N, Weiss WA, Moxon-Emre I, Mabbott DJ, Lassaletta A, Hawkins CE, Tabori U, Drake J, Kulkarni A, Dirks P, Rutka JT, Korshunov A, Pfister SM, Packer RJ, Ramaswamy V, Taylor MD (2016) Prognostic value of medulloblastoma extent of resection after accounting for molecular subgroup: a retrospective integrated clinical and molecular analysis. Lancet Oncol 17:484–495. https://​doi.​org/​10.​1016/​s1470-2045(15)00581-1CrossRefPubMedPubMedCentral

go back to reference Taylor MD, Northcott PA, Korshunov A, Remke M, Cho YJ, Clifford SC, Eberhart CG, Parsons DW, Rutkowski S, Gajjar A, Ellison DW, Lichter P, Gilbertson RJ, Pomeroy SL, Kool M, Pfister SM (2012) Molecular subgroups of medulloblastoma: the current consensus. Acta Neuropathol 123:465–472. https://doi.org/10.1007/s00401-011-0922-zCrossRefPubMed Taylor MD, Northcott PA, Korshunov A, Remke M, Cho YJ, Clifford SC, Eberhart CG, Parsons DW, Rutkowski S, Gajjar A, Ellison DW, Lichter P, Gilbertson RJ, Pomeroy SL, Kool M, Pfister SM (2012) Molecular subgroups of medulloblastoma: the current consensus. Acta Neuropathol 123:465–472. https://​doi.​org/​10.​1007/​s00401-011-0922-zCrossRefPubMed

go back to reference Thompson EM, Keir ST, Venkatraman T, Lascola C, Yeom KW, Nixon AB, Liu Y, Picard D, Remke M, Bigner DD, Ramaswamy V, Taylor MD (2017) The role of angiogenesis in Group 3 medulloblastoma pathogenesis and survival. Neuro Oncol 19:1217–1227. https://doi.org/10.1093/neuonc/nox033CrossRefPubMedPubMedCentral Thompson EM, Keir ST, Venkatraman T, Lascola C, Yeom KW, Nixon AB, Liu Y, Picard D, Remke M, Bigner DD, Ramaswamy V, Taylor MD (2017) The role of angiogenesis in Group 3 medulloblastoma pathogenesis and survival. Neuro Oncol 19:1217–1227. https://​doi.​org/​10.​1093/​neuonc/​nox033CrossRefPubMedPubMedCentral

go back to reference Perreault S, Ramaswamy V, Achrol AS, Chao K, Liu TT, Shih D, Remke M, Schubert S, Bouffet E, Fisher PG, Partap S, Vogel H, Taylor MD, Cho YJ, Yeom KW (2014) MRI surrogates for molecular subgroups of medulloblastoma. AJNR Am J Neuroradiol 35:1263–1269. https://doi.org/10.3174/ajnr.A3990CrossRefPubMedPubMedCentral Perreault S, Ramaswamy V, Achrol AS, Chao K, Liu TT, Shih D, Remke M, Schubert S, Bouffet E, Fisher PG, Partap S, Vogel H, Taylor MD, Cho YJ, Yeom KW (2014) MRI surrogates for molecular subgroups of medulloblastoma. AJNR Am J Neuroradiol 35:1263–1269. https://​doi.​org/​10.​3174/​ajnr.​A3990CrossRefPubMedPubMedCentral

go back to reference Thompson EM, Bramall A, Herndon JE 2nd, Taylor MD, Ramaswamy V (2018) The clinical importance of medulloblastoma extent of resection: a systematic review. J Neurooncol 139:523–539. https://doi.org/10.1007/s11060-018-2906-5CrossRefPubMed Thompson EM, Bramall A, Herndon JE 2nd, Taylor MD, Ramaswamy V (2018) The clinical importance of medulloblastoma extent of resection: a systematic review. J Neurooncol 139:523–539. https://​doi.​org/​10.​1007/​s11060-018-2906-5CrossRefPubMed

go back to reference Bailey P, Cushing H (1925) Medulloblastoma cerebelli: a common type of midcerebellar glioma of childhood. Arch Neurol Psychiatry 14:192–224CrossRef Bailey P, Cushing H (1925) Medulloblastoma cerebelli: a common type of midcerebellar glioma of childhood. Arch Neurol Psychiatry 14:192–224CrossRef

go back to reference Cheney MS, Hosmer FE, Lucas K (1987) Russell L. Drake: an historical retrospective. J Biocommun 14:7–11, 15–22 Cheney MS, Hosmer FE, Lucas K (1987) Russell L. Drake: an historical retrospective. J Biocommun 14:7–11, 15–22

go back to reference Penfield W (1931) The classification of gliomas and neuroglia cell types. Arch Neurol Psychiatry 26:745–753CrossRef Penfield W (1931) The classification of gliomas and neuroglia cell types. Arch Neurol Psychiatry 26:745–753CrossRef

go back to reference Cushing H (1930) Experiences with the cerebellar medulloblastomas: a critical review 1. Acta Pathologica Microbiologica Scandinavica 7:1–86CrossRef Cushing H (1930) Experiences with the cerebellar medulloblastomas: a critical review 1. Acta Pathologica Microbiologica Scandinavica 7:1–86CrossRef

go back to reference Cushing HW (1932) Intracranial tumours: notes upon a series of two thousand verified cases with surgical-mortality percentages pertaining thereto. CC Thomas Cushing HW (1932) Intracranial tumours: notes upon a series of two thousand verified cases with surgical-mortality percentages pertaining thereto. CC Thomas

go back to reference Paterson E, Farr RF (1953) Cerebellar medulloblastoma: treatment by irradiation of the whole central nervous system. Acta radiol 39:323–336. https://doi.org/10.3109/00016925309136718CrossRefPubMed Paterson E, Farr RF (1953) Cerebellar medulloblastoma: treatment by irradiation of the whole central nervous system. Acta radiol 39:323–336. https://​doi.​org/​10.​3109/​0001692530913671​8CrossRefPubMed

go back to reference Ingraham FD, Bailey OT, Barker WF (1948) Medulloblastoma cerebelli; diagnosis, treatment and survivals, with a report of 56 cases. N Engl J Med 238:171–174. https://doi.org/10.1056/nejm194802052380601CrossRefPubMed Ingraham FD, Bailey OT, Barker WF (1948) Medulloblastoma cerebelli; diagnosis, treatment and survivals, with a report of 56 cases. N Engl J Med 238:171–174. https://​doi.​org/​10.​1056/​nejm194802052380​601CrossRefPubMed

go back to reference Christopherson KM, Rotondo RL, Bradley JA, Pincus DW, Wynn TT, Fort JA, Morris CG, Mendenhall NP, Marcus RB Jr, Indelicato DJ (2014) Late toxicity following craniospinal radiation for early-stage medulloblastoma. Acta Oncol 53:471–480. https://doi.org/10.3109/0284186x.2013.862596CrossRefPubMed Christopherson KM, Rotondo RL, Bradley JA, Pincus DW, Wynn TT, Fort JA, Morris CG, Mendenhall NP, Marcus RB Jr, Indelicato DJ (2014) Late toxicity following craniospinal radiation for early-stage medulloblastoma. Acta Oncol 53:471–480. https://​doi.​org/​10.​3109/​0284186x.​2013.​862596CrossRefPubMed

go back to reference Heitzer AM, Ashford JM, Harel BT, Schembri A, Swain MA, Wallace J, Ness KK, Wang F, Zhang H, Merchant TE, Robinson GW, Gajjar A, Conklin HM (2019) Computerized assessment of cognitive impairment among children undergoing radiation therapy for medulloblastoma. J Neurooncol 141:403–411. https://doi.org/10.1007/s11060-018-03046-2CrossRefPubMed Heitzer AM, Ashford JM, Harel BT, Schembri A, Swain MA, Wallace J, Ness KK, Wang F, Zhang H, Merchant TE, Robinson GW, Gajjar A, Conklin HM (2019) Computerized assessment of cognitive impairment among children undergoing radiation therapy for medulloblastoma. J Neurooncol 141:403–411. https://​doi.​org/​10.​1007/​s11060-018-03046-2CrossRefPubMed

go back to reference Lafay-Cousin L, Bouffet E, Hawkins C, Amid A, Huang A, Mabbott DJ (2009) Impact of radiation avoidance on survival and neurocognitive outcome in infant medulloblastoma. Curr Oncol 16:21–28. https://doi.org/10.3747/co.v16i6.435CrossRefPubMedPubMedCentral Lafay-Cousin L, Bouffet E, Hawkins C, Amid A, Huang A, Mabbott DJ (2009) Impact of radiation avoidance on survival and neurocognitive outcome in infant medulloblastoma. Curr Oncol 16:21–28. https://​doi.​org/​10.​3747/​co.​v16i6.​435CrossRefPubMedPubMedCentral

go back to reference Tait DM, Thornton-Jones H, Bloom HJ, Lemerle J, Morris-Jones P (1990) Adjuvant chemotherapy for medulloblastoma: the first multi-centre control trial of the International Society of Paediatric Oncology (SIOP I). Eur J Cancer 26:464–469CrossRefPubMed Tait DM, Thornton-Jones H, Bloom HJ, Lemerle J, Morris-Jones P (1990) Adjuvant chemotherapy for medulloblastoma: the first multi-centre control trial of the International Society of Paediatric Oncology (SIOP I). Eur J Cancer 26:464–469CrossRefPubMed

go back to reference Packer RJ, Sutton LN, Elterman R, Lange B, Goldwein J, Nicholson HS, Mulne L, Boyett J, D'Angio G, Wechsler-Jentzsch K et al (1994) Outcome for children with medulloblastoma treated with radiation and cisplatin, CCNU, and vincristine chemotherapy. J Neurosurg 81:690–698. https://doi.org/10.3171/jns.1994.81.5.0690CrossRefPubMed Packer RJ, Sutton LN, Elterman R, Lange B, Goldwein J, Nicholson HS, Mulne L, Boyett J, D'Angio G, Wechsler-Jentzsch K et al (1994) Outcome for children with medulloblastoma treated with radiation and cisplatin, CCNU, and vincristine chemotherapy. J Neurosurg 81:690–698. https://​doi.​org/​10.​3171/​jns.​1994.​81.​5.​0690CrossRefPubMed

go back to reference Packer RJ, Sutton LN, Goldwein JW, Perilongo G, Bunin G, Ryan J, Cohen BH, D’Angio G, Kramer ED, Zimmerman RA et al (1991) Improved survival with the use of adjuvant chemotherapy in the treatment of medulloblastoma. J Neurosurg 74:433–440. https://doi.org/10.3171/jns.1991.74.3.0433CrossRefPubMed Packer RJ, Sutton LN, Goldwein JW, Perilongo G, Bunin G, Ryan J, Cohen BH, D’Angio G, Kramer ED, Zimmerman RA et al (1991) Improved survival with the use of adjuvant chemotherapy in the treatment of medulloblastoma. J Neurosurg 74:433–440. https://​doi.​org/​10.​3171/​jns.​1991.​74.​3.​0433CrossRefPubMed

go back to reference Packer RJ, Siegel KR, Sutton LN, Evans AE, D’Angio G, Rorke LB, Bunin GR, Schut L (1988) Efficacy of adjuvant chemotherapy for patients with poor-risk medulloblastoma: a preliminary report. Ann Neurol 24:503–508. https://doi.org/10.1002/ana.410240405CrossRefPubMed Packer RJ, Siegel KR, Sutton LN, Evans AE, D’Angio G, Rorke LB, Bunin GR, Schut L (1988) Efficacy of adjuvant chemotherapy for patients with poor-risk medulloblastoma: a preliminary report. Ann Neurol 24:503–508. https://​doi.​org/​10.​1002/​ana.​410240405CrossRefPubMed

go back to reference Liu X, Ding C, Tan W, Zhang A (2020) Medulloblastoma: molecular understanding, treatment evolution, and new developments. Pharmacol Ther 210:107516. https://doi.org/10.1016/j.pharmthera.2020.107516CrossRefPubMed Liu X, Ding C, Tan W, Zhang A (2020) Medulloblastoma: molecular understanding, treatment evolution, and new developments. Pharmacol Ther 210:107516. https://​doi.​org/​10.​1016/​j.​pharmthera.​2020.​107516CrossRefPubMed

go back to reference Rorke LB (1983) The cerebellar medulloblastoma and its relationship to primitive neuroectodermal tumors. J Neuropathol Exp Neurol 42:1–15CrossRefPubMed Rorke LB (1983) The cerebellar medulloblastoma and its relationship to primitive neuroectodermal tumors. J Neuropathol Exp Neurol 42:1–15CrossRefPubMed

go back to reference Albright AL, Wisoff JH, Zeltzer PM, Boyett JM, Rorke LB, Stanley P (1996) Effects of medulloblastoma resections on outcome in children: a report from the Children’s Cancer Group. Neurosurgery 38:265–271. https://doi.org/10.1097/00006123-199602000-00007CrossRefPubMed Albright AL, Wisoff JH, Zeltzer PM, Boyett JM, Rorke LB, Stanley P (1996) Effects of medulloblastoma resections on outcome in children: a report from the Children’s Cancer Group. Neurosurgery 38:265–271. https://​doi.​org/​10.​1097/​00006123-199602000-00007CrossRefPubMed

go back to reference Pietsch T, Schmidt R, Remke M, Korshunov A, Hovestadt V, Jones DT, Felsberg J, Kaulich K, Goschzik T, Kool M, Northcott PA, von Hoff K, von Bueren AO, Friedrich C, Mynarek M, Skladny H, Fleischhack G, Taylor MD, Cremer F, Lichter P, Faldum A, Reifenberger G, Rutkowski S, Pfister SM (2014) Prognostic significance of clinical, histopathological, and molecular characteristics of medulloblastomas in the prospective HIT2000 multicenter clinical trial cohort. Acta Neuropathol 128:137–149. https://doi.org/10.1007/s00401-014-1276-0CrossRefPubMedPubMedCentral Pietsch T, Schmidt R, Remke M, Korshunov A, Hovestadt V, Jones DT, Felsberg J, Kaulich K, Goschzik T, Kool M, Northcott PA, von Hoff K, von Bueren AO, Friedrich C, Mynarek M, Skladny H, Fleischhack G, Taylor MD, Cremer F, Lichter P, Faldum A, Reifenberger G, Rutkowski S, Pfister SM (2014) Prognostic significance of clinical, histopathological, and molecular characteristics of medulloblastomas in the prospective HIT2000 multicenter clinical trial cohort. Acta Neuropathol 128:137–149. https://​doi.​org/​10.​1007/​s00401-014-1276-0CrossRefPubMedPubMedCentral

go back to reference Goschzik T, Schwalbe EC, Hicks D, Smith A, Zur Muehlen A, Figarella-Branger D, Doz F, Rutkowski S, Lannering B, Pietsch T, Clifford SC (2018) Prognostic effect of whole chromosomal aberration signatures in standard-risk, non-WNT/non-SHH medulloblastoma: a retrospective, molecular analysis of the HIT-SIOP PNET 4 trial. Lancet Oncol 19:1602–1616. https://doi.org/10.1016/s1470-2045(18)30532-1CrossRefPubMedPubMedCentral Goschzik T, Schwalbe EC, Hicks D, Smith A, Zur Muehlen A, Figarella-Branger D, Doz F, Rutkowski S, Lannering B, Pietsch T, Clifford SC (2018) Prognostic effect of whole chromosomal aberration signatures in standard-risk, non-WNT/non-SHH medulloblastoma: a retrospective, molecular analysis of the HIT-SIOP PNET 4 trial. Lancet Oncol 19:1602–1616. https://​doi.​org/​10.​1016/​s1470-2045(18)30532-1CrossRefPubMedPubMedCentral

go back to reference Hovestadt V, Ayrault O, Swartling FJ, Robinson GW, Pfister SM, Northcott PA (2020) Medulloblastomics revisited: biological and clinical insights from thousands of patients. Nat Rev Cancer 20:42–56. https://doi.org/10.1038/s41568-019-0223-8CrossRefPubMed Hovestadt V, Ayrault O, Swartling FJ, Robinson GW, Pfister SM, Northcott PA (2020) Medulloblastomics revisited: biological and clinical insights from thousands of patients. Nat Rev Cancer 20:42–56. https://​doi.​org/​10.​1038/​s41568-019-0223-8CrossRefPubMed

go back to reference Robinson GW, Gajjar A (2020) Genomics paves the way for better infant medulloblastoma therapy. J Clin Oncol 38:2010–2013. https://doi.org/10.1200/jco.20.00593CrossRefPubMedPubMedCentral Robinson GW, Gajjar A (2020) Genomics paves the way for better infant medulloblastoma therapy. J Clin Oncol 38:2010–2013. https://​doi.​org/​10.​1200/​jco.​20.​00593CrossRefPubMedPubMedCentral

go back to reference Kumar R, Liu APY, Northcott PA (2020) Medulloblastoma genomics in the modern molecular era. Brain Pathol 30:679–690. https://doi.org/10.1111/bpa.12804CrossRefPubMed Kumar R, Liu APY, Northcott PA (2020) Medulloblastoma genomics in the modern molecular era. Brain Pathol 30:679–690. https://​doi.​org/​10.​1111/​bpa.​12804CrossRefPubMed

go back to reference Massimino M, Antonelli M, Gandola L, Miceli R, Pollo B, Biassoni V, Schiavello E, Buttarelli FR, Spreafico F, Collini P, Giangaspero F (2013) Histological variants of medulloblastoma are the most powerful clinical prognostic indicators. Pediatr Blood Cancer 60:210–216. https://doi.org/10.1002/pbc.24225CrossRefPubMed Massimino M, Antonelli M, Gandola L, Miceli R, Pollo B, Biassoni V, Schiavello E, Buttarelli FR, Spreafico F, Collini P, Giangaspero F (2013) Histological variants of medulloblastoma are the most powerful clinical prognostic indicators. Pediatr Blood Cancer 60:210–216. https://​doi.​org/​10.​1002/​pbc.​24225CrossRefPubMed

go back to reference Korshunov A, Sahm F, Zheludkova O, Golanov A, Stichel D, Schrimpf D, Ryzhova M, Potapov A, Habel A, Meyer J, Lichter P, Jones DTW, von Deimling A, Pfister SM, Kool M (2019) DNA methylation profiling is a method of choice for molecular verification of pediatric WNT-activated medulloblastomas. Neuro Oncol 21:214–221. https://doi.org/10.1093/neuonc/noy155CrossRefPubMed Korshunov A, Sahm F, Zheludkova O, Golanov A, Stichel D, Schrimpf D, Ryzhova M, Potapov A, Habel A, Meyer J, Lichter P, Jones DTW, von Deimling A, Pfister SM, Kool M (2019) DNA methylation profiling is a method of choice for molecular verification of pediatric WNT-activated medulloblastomas. Neuro Oncol 21:214–221. https://​doi.​org/​10.​1093/​neuonc/​noy155CrossRefPubMed

go back to reference Sursal T, Ronecker JS, Dicpinigaitis AJ, Mohan AL, Tobias ME, Gandhi CD, Jhanwar-Uniyal M (2022) Molecular stratification of medulloblastoma: clinical outcomes and therapeutic interventions. Anticancer Res 42:2225–2239. https://doi.org/10.21873/anticanres.15703CrossRefPubMed Sursal T, Ronecker JS, Dicpinigaitis AJ, Mohan AL, Tobias ME, Gandhi CD, Jhanwar-Uniyal M (2022) Molecular stratification of medulloblastoma: clinical outcomes and therapeutic interventions. Anticancer Res 42:2225–2239. https://​doi.​org/​10.​21873/​anticanres.​15703CrossRefPubMed

go back to reference Pei Y, Moore CE, Wang J, Tewari AK, Eroshkin A, Cho YJ, Witt H, Korshunov A, Read TA, Sun JL, Schmitt EM, Miller CR, Buckley AF, McLendon RE, Westbrook TF, Northcott PA, Taylor MD, Pfister SM, Febbo PG, Wechsler-Reya RJ (2012) An animal model of MYC-driven medulloblastoma. Cancer Cell 21:155–167. https://doi.org/10.1016/j.ccr.2011.12.021CrossRefPubMedPubMedCentral Pei Y, Moore CE, Wang J, Tewari AK, Eroshkin A, Cho YJ, Witt H, Korshunov A, Read TA, Sun JL, Schmitt EM, Miller CR, Buckley AF, McLendon RE, Westbrook TF, Northcott PA, Taylor MD, Pfister SM, Febbo PG, Wechsler-Reya RJ (2012) An animal model of MYC-driven medulloblastoma. Cancer Cell 21:155–167. https://​doi.​org/​10.​1016/​j.​ccr.​2011.​12.​021CrossRefPubMedPubMedCentral

go back to reference Northcott PA, Buchhalter I, Morrissy AS, Hovestadt V, Weischenfeldt J, Ehrenberger T, Gröbner S, Segura-Wang M, Zichner T, Rudneva VA, Warnatz HJ, Sidiropoulos N, Phillips AH, Schumacher S, Kleinheinz K, Waszak SM, Erkek S, Jones DTW, Worst BC, Kool M, Zapatka M, Jäger N, Chavez L, Hutter B, Bieg M, Paramasivam N, Heinold M, Gu Z, Ishaque N, Jäger-Schmidt C, Imbusch CD, Jugold A, Hübschmann D, Risch T, Amstislavskiy V, Gonzalez FGR, Weber UD, Wolf S, Robinson GW, Zhou X, Wu G, Finkelstein D, Liu Y, Cavalli FMG, Luu B, Ramaswamy V, Wu X, Koster J, Ryzhova M, Cho YJ, Pomeroy SL, Herold-Mende C, Schuhmann M, Ebinger M, Liau LM, Mora J, McLendon RE, Jabado N, Kumabe T, Chuah E, Ma Y, Moore RA, Mungall AJ, Mungall KL, Thiessen N, Tse K, Wong T, Jones SJM, Witt O, Milde T, Von Deimling A, Capper D, Korshunov A, Yaspo ML, Kriwacki R, Gajjar A, Zhang J, Beroukhim R, Fraenkel E, Korbel JO, Brors B, Schlesner M, Eils R, Marra MA, Pfister SM, Taylor MD, Lichter P (2017) The whole-genome landscape of medulloblastoma subtypes. Nature 547:311–317. https://doi.org/10.1038/nature22973CrossRefPubMedPubMedCentral Northcott PA, Buchhalter I, Morrissy AS, Hovestadt V, Weischenfeldt J, Ehrenberger T, Gröbner S, Segura-Wang M, Zichner T, Rudneva VA, Warnatz HJ, Sidiropoulos N, Phillips AH, Schumacher S, Kleinheinz K, Waszak SM, Erkek S, Jones DTW, Worst BC, Kool M, Zapatka M, Jäger N, Chavez L, Hutter B, Bieg M, Paramasivam N, Heinold M, Gu Z, Ishaque N, Jäger-Schmidt C, Imbusch CD, Jugold A, Hübschmann D, Risch T, Amstislavskiy V, Gonzalez FGR, Weber UD, Wolf S, Robinson GW, Zhou X, Wu G, Finkelstein D, Liu Y, Cavalli FMG, Luu B, Ramaswamy V, Wu X, Koster J, Ryzhova M, Cho YJ, Pomeroy SL, Herold-Mende C, Schuhmann M, Ebinger M, Liau LM, Mora J, McLendon RE, Jabado N, Kumabe T, Chuah E, Ma Y, Moore RA, Mungall AJ, Mungall KL, Thiessen N, Tse K, Wong T, Jones SJM, Witt O, Milde T, Von Deimling A, Capper D, Korshunov A, Yaspo ML, Kriwacki R, Gajjar A, Zhang J, Beroukhim R, Fraenkel E, Korbel JO, Brors B, Schlesner M, Eils R, Marra MA, Pfister SM, Taylor MD, Lichter P (2017) The whole-genome landscape of medulloblastoma subtypes. Nature 547:311–317. https://​doi.​org/​10.​1038/​nature22973CrossRefPubMedPubMedCentral

go back to reference Brown NJ, Wilson B, Shahrestani S, Choi EH, Lien BV, Paladugu A, Tran K, Ransom SC, Tafreshi AR, Ransom RC, Sahyouni R, Chan AY, Yang I (2021) The 100 most influential publications on medulloblastoma: areas of past, current, and future focus. World Neurosurg 146:119–139. https://doi.org/10.1016/j.wneu.2020.11.038CrossRefPubMed Brown NJ, Wilson B, Shahrestani S, Choi EH, Lien BV, Paladugu A, Tran K, Ransom SC, Tafreshi AR, Ransom RC, Sahyouni R, Chan AY, Yang I (2021) The 100 most influential publications on medulloblastoma: areas of past, current, and future focus. World Neurosurg 146:119–139. https://​doi.​org/​10.​1016/​j.​wneu.​2020.​11.​038CrossRefPubMed

go back to reference Thompson EM, Ashley D, Landi D (2020) Current medulloblastoma subgroup specific clinical trials. Transl Pediatr 9:157–162. https://doi.org/10.21037/tp.2020.03.03CrossRefPubMedPubMedCentral Thompson EM, Ashley D, Landi D (2020) Current medulloblastoma subgroup specific clinical trials. Transl Pediatr 9:157–162. https://​doi.​org/​10.​21037/​tp.​2020.​03.​03CrossRefPubMedPubMedCentral

go back to reference Khatua S, Song A, Citla Sridhar D, Mack SC (2018) Childhood medulloblastoma: current therapies, emerging molecular landscape and newer therapeutic insights. Curr Neuropharmacol 16:1045–1058. https://doi.org/10.2174/1570159x15666171129111324CrossRefPubMedPubMedCentral Khatua S, Song A, Citla Sridhar D, Mack SC (2018) Childhood medulloblastoma: current therapies, emerging molecular landscape and newer therapeutic insights. Curr Neuropharmacol 16:1045–1058. https://​doi.​org/​10.​2174/​1570159x15666171​129111324CrossRefPubMedPubMedCentral

go back to reference Juraschka K, Taylor MD (2019) Medulloblastoma in the age of molecular subgroups: a review. J Neurosurg Pediatr 24:353–363. https://doi.org/10.3171/2019.5.Peds18381CrossRefPubMed Juraschka K, Taylor MD (2019) Medulloblastoma in the age of molecular subgroups: a review. J Neurosurg Pediatr 24:353–363. https://​doi.​org/​10.​3171/​2019.​5.​Peds18381CrossRefPubMed

go back to reference Hendrikse LD, Haldipur P, Saulnier O, Millman J, Sjoboen AH, Erickson AW, Ong W, Gordon V, Coudière-Morrison L, Mercier AL, Shokouhian M, Suárez RA, Ly M, Borlase S, Scott DS, Vladoiu MC, Farooq H, Sirbu O, Nakashima T, Nambu S, Funakoshi Y, Bahcheli A, Diaz-Mejia JJ, Golser J, Bach K, Phuong-Bao T, Skowron P, Wang EY, Kumar SA, Balin P, Visvanathan A, Lee JJY, Ayoub R, Chen X, Chen X, Mungall KL, Luu B, Bérubé P, Wang YC, Pfister SM, Kim SK, Delattre O, Bourdeaut F, Doz F, Masliah-Planchon J, Grajkowska WA, Loukides J, Dirks P, Fèvre-Montange M, Jouvet A, French PJ, Kros JM, Zitterbart K, Bailey SD, Eberhart CG, Rao AAN, Giannini C, Olson JM, Garami M, Hauser P, Phillips JJ, Ra YS, de Torres C, Mora J, Li KKW, Ng HK, Poon WS, Pollack IF, López-Aguilar E, Gillespie GY, Van Meter TE, Shofuda T, Vibhakar R, Thompson RC, Cooper MK, Rubin JB, Kumabe T, Jung S, Lach B, Iolascon A, Ferrucci V, de Antonellis P, Zollo M, Cinalli G, Robinson S, Stearns DS, Van Meir EG, Porrati P, Finocchiaro G, Massimino M, Carlotti CG, Faria CC, Roussel MF, Boop F, Chan JA, Aldinger KA, Razavi F, Silvestri E, McLendon RE, Thompson EM, Ansari M, Garre ML, Chico F, Eguía P, Pérezpeña M, Morrissy AS, Cavalli FMG, Wu X, Daniels C, Rich JN, Jones SJM, Moore RA, Marra MA, Huang X, Reimand J, Sorensen PH, Wechsler-Reya RJ, Weiss WA, Pugh TJ, Garzia L, Kleinman CL, Stein LD, Jabado N, Malkin D, Ayrault O, Golden JA, Ellison DW, Doble B, Ramaswamy V, Werbowetski-Ogilvie TE, Suzuki H, Millen KJ, Taylor MD (2022) Failure of human rhombic lip differentiation underlies medulloblastoma formation. Nature 609:1021–1028. https://doi.org/10.1038/s41586-022-05215-wCrossRefPubMedPubMedCentral Hendrikse LD, Haldipur P, Saulnier O, Millman J, Sjoboen AH, Erickson AW, Ong W, Gordon V, Coudière-Morrison L, Mercier AL, Shokouhian M, Suárez RA, Ly M, Borlase S, Scott DS, Vladoiu MC, Farooq H, Sirbu O, Nakashima T, Nambu S, Funakoshi Y, Bahcheli A, Diaz-Mejia JJ, Golser J, Bach K, Phuong-Bao T, Skowron P, Wang EY, Kumar SA, Balin P, Visvanathan A, Lee JJY, Ayoub R, Chen X, Chen X, Mungall KL, Luu B, Bérubé P, Wang YC, Pfister SM, Kim SK, Delattre O, Bourdeaut F, Doz F, Masliah-Planchon J, Grajkowska WA, Loukides J, Dirks P, Fèvre-Montange M, Jouvet A, French PJ, Kros JM, Zitterbart K, Bailey SD, Eberhart CG, Rao AAN, Giannini C, Olson JM, Garami M, Hauser P, Phillips JJ, Ra YS, de Torres C, Mora J, Li KKW, Ng HK, Poon WS, Pollack IF, López-Aguilar E, Gillespie GY, Van Meter TE, Shofuda T, Vibhakar R, Thompson RC, Cooper MK, Rubin JB, Kumabe T, Jung S, Lach B, Iolascon A, Ferrucci V, de Antonellis P, Zollo M, Cinalli G, Robinson S, Stearns DS, Van Meir EG, Porrati P, Finocchiaro G, Massimino M, Carlotti CG, Faria CC, Roussel MF, Boop F, Chan JA, Aldinger KA, Razavi F, Silvestri E, McLendon RE, Thompson EM, Ansari M, Garre ML, Chico F, Eguía P, Pérezpeña M, Morrissy AS, Cavalli FMG, Wu X, Daniels C, Rich JN, Jones SJM, Moore RA, Marra MA, Huang X, Reimand J, Sorensen PH, Wechsler-Reya RJ, Weiss WA, Pugh TJ, Garzia L, Kleinman CL, Stein LD, Jabado N, Malkin D, Ayrault O, Golden JA, Ellison DW, Doble B, Ramaswamy V, Werbowetski-Ogilvie TE, Suzuki H, Millen KJ, Taylor MD (2022) Failure of human rhombic lip differentiation underlies medulloblastoma formation. Nature 609:1021–1028. https://​doi.​org/​10.​1038/​s41586-022-05215-wCrossRefPubMedPubMedCentral

go back to reference Watson C (2017) A new mammalian brain ontology based on developmental gene expressioni In: Kaas JH (ed) Evolution of Nervous Systems 2edn. Science Direct Watson C (2017) A new mammalian brain ontology based on developmental gene expressioni In: Kaas JH (ed) Evolution of Nervous Systems 2edn. Science Direct

go back to reference Komuro Y, Kumada T, Komuro H (2013) Migration in the Cerebellum. Elsevier Inc Komuro Y, Kumada T, Komuro H (2013) Migration in the Cerebellum. Elsevier Inc

go back to reference Luo Z, Xia M, Shi W, Zhao C, Wang J, Xin D, Dong X, Xiong Y, Zhang F, Berry K, Ogurek S, Liu X, Rao R, Xing R, Wu LMN, Cui S, Xu L, Lin Y, Ma W, Tian S, Xie Q, Zhang L, Xin M, Wang X, Yue F, Zheng H, Liu Y, Stevenson CB, de Blank P, Perentesis JP, Gilbertson RJ, Li H, Ma J, Zhou W, Taylor MD, Lu QR (2022) Human fetal cerebellar cell atlas informs medulloblastoma origin and oncogenesis. Nature 612:787–794. https://doi.org/10.1038/s41586-022-05487-2CrossRefPubMed Luo Z, Xia M, Shi W, Zhao C, Wang J, Xin D, Dong X, Xiong Y, Zhang F, Berry K, Ogurek S, Liu X, Rao R, Xing R, Wu LMN, Cui S, Xu L, Lin Y, Ma W, Tian S, Xie Q, Zhang L, Xin M, Wang X, Yue F, Zheng H, Liu Y, Stevenson CB, de Blank P, Perentesis JP, Gilbertson RJ, Li H, Ma J, Zhou W, Taylor MD, Lu QR (2022) Human fetal cerebellar cell atlas informs medulloblastoma origin and oncogenesis. Nature 612:787–794. https://​doi.​org/​10.​1038/​s41586-022-05487-2CrossRefPubMed

go back to reference Hashimoto Y, Penas-Prado M, Zhou S, Wei J, Khatua S, Hodges TR, Sanai N, Xiu J, Gatalica Z, Kim L, Kesari S, Rao G, Spetzler D, Heimberger A (2018) Rethinking medulloblastoma from a targeted therapeutics perspective. J Neurooncol 139:713–720. https://doi.org/10.1007/s11060-018-2917-2CrossRefPubMedPubMedCentral Hashimoto Y, Penas-Prado M, Zhou S, Wei J, Khatua S, Hodges TR, Sanai N, Xiu J, Gatalica Z, Kim L, Kesari S, Rao G, Spetzler D, Heimberger A (2018) Rethinking medulloblastoma from a targeted therapeutics perspective. J Neurooncol 139:713–720. https://​doi.​org/​10.​1007/​s11060-018-2917-2CrossRefPubMedPubMedCentral

go back to reference Zeltzer PM, Boyett JM, Finlay JL, Albright AL, Rorke LB, Milstein JM, Allen JC, Stevens KR, Stanley P, Li H, Wisoff JH, Geyer JR, McGuire-Cullen P, Stehbens JA, Shurin SB, Packer RJ (1999) Metastasis stage, adjuvant treatment, and residual tumor are prognostic factors for medulloblastoma in children: conclusions from the Children’s Cancer Group 921 randomized phase III study. J Clin Oncol 17:832–845. https://doi.org/10.1200/jco.1999.17.3.832CrossRefPubMed Zeltzer PM, Boyett JM, Finlay JL, Albright AL, Rorke LB, Milstein JM, Allen JC, Stevens KR, Stanley P, Li H, Wisoff JH, Geyer JR, McGuire-Cullen P, Stehbens JA, Shurin SB, Packer RJ (1999) Metastasis stage, adjuvant treatment, and residual tumor are prognostic factors for medulloblastoma in children: conclusions from the Children’s Cancer Group 921 randomized phase III study. J Clin Oncol 17:832–845. https://​doi.​org/​10.​1200/​jco.​1999.​17.​3.​832CrossRefPubMed

go back to reference Brasme JF, Grill J, Doz F, Lacour B, Valteau-Couanet D, Gaillard S, Delalande O, Aghakhani N, Puget S, Chalumeau M (2012) Long time to diagnosis of medulloblastoma in children is not associated with decreased survival or with worse neurological outcome. PLoS ONE 7:e33415. https://doi.org/10.1371/journal.pone.0033415CrossRefPubMedPubMedCentral Brasme JF, Grill J, Doz F, Lacour B, Valteau-Couanet D, Gaillard S, Delalande O, Aghakhani N, Puget S, Chalumeau M (2012) Long time to diagnosis of medulloblastoma in children is not associated with decreased survival or with worse neurological outcome. PLoS ONE 7:e33415. https://​doi.​org/​10.​1371/​journal.​pone.​0033415CrossRefPubMedPubMedCentral

go back to reference Rutkowski S, von Hoff K, Emser A, Zwiener I, Pietsch T, Figarella-Branger D, Giangaspero F, Ellison DW, Garre ML, Biassoni V, Grundy RG, Finlay JL, Dhall G, Raquin MA, Grill J (2010) Survival and prognostic factors of early childhood medulloblastoma: an international meta-analysis. J Clin Oncol 28:4961–4968. https://doi.org/10.1200/jco.2010.30.2299CrossRefPubMed Rutkowski S, von Hoff K, Emser A, Zwiener I, Pietsch T, Figarella-Branger D, Giangaspero F, Ellison DW, Garre ML, Biassoni V, Grundy RG, Finlay JL, Dhall G, Raquin MA, Grill J (2010) Survival and prognostic factors of early childhood medulloblastoma: an international meta-analysis. J Clin Oncol 28:4961–4968. https://​doi.​org/​10.​1200/​jco.​2010.​30.​2299CrossRefPubMed

go back to reference Packer RJ, Boyett JM, Janss AJ, Stavrou T, Kun L, Wisoff J, Russo C, Geyer R, Phillips P, Kieran M, Greenberg M, Goldman S, Hyder D, Heideman R, Jones-Wallace D, August GP, Smith SH, Moshang T (2001) Growth hormone replacement therapy in children with medulloblastoma: use and effect on tumor control. J Clin Oncol 19:480–487. https://doi.org/10.1200/jco.2001.19.2.480CrossRefPubMed Packer RJ, Boyett JM, Janss AJ, Stavrou T, Kun L, Wisoff J, Russo C, Geyer R, Phillips P, Kieran M, Greenberg M, Goldman S, Hyder D, Heideman R, Jones-Wallace D, August GP, Smith SH, Moshang T (2001) Growth hormone replacement therapy in children with medulloblastoma: use and effect on tumor control. J Clin Oncol 19:480–487. https://​doi.​org/​10.​1200/​jco.​2001.​19.​2.​480CrossRefPubMed

go back to reference Johnston DL, Keene D, Bartels U, Carret AS, Crooks B, Eisenstat DD, Fryer C, Lafay-Cousin L, Larouche V, Moghrabi A, Wilson B, Zelcer S, Silva M, Brossard J, Bouffet E (2009) Medulloblastoma in children under the age of three years: a retrospective Canadian review. J Neurooncol 94:51–56. https://doi.org/10.1007/s11060-009-9799-2CrossRefPubMed Johnston DL, Keene D, Bartels U, Carret AS, Crooks B, Eisenstat DD, Fryer C, Lafay-Cousin L, Larouche V, Moghrabi A, Wilson B, Zelcer S, Silva M, Brossard J, Bouffet E (2009) Medulloblastoma in children under the age of three years: a retrospective Canadian review. J Neurooncol 94:51–56. https://​doi.​org/​10.​1007/​s11060-009-9799-2CrossRefPubMed

go back to reference Akyüz C, Varan A, Küpeli S, Akalan N, Söylemezoglu F, Zorlu F, Kutluk T, Büyükpamukçu M (2008) Medulloblastoma in children: a 32-year experience from a single institution. J Neurooncol 90:99–103. https://doi.org/10.1007/s11060-008-9638-xCrossRefPubMed Akyüz C, Varan A, Küpeli S, Akalan N, Söylemezoglu F, Zorlu F, Kutluk T, Büyükpamukçu M (2008) Medulloblastoma in children: a 32-year experience from a single institution. J Neurooncol 90:99–103. https://​doi.​org/​10.​1007/​s11060-008-9638-xCrossRefPubMed

go back to reference Evans AE, Jenkin RD, Sposto R, Ortega JA, Wilson CB, Wara W, Ertel IJ, Kramer S, Chang CH, Leikin SL et al (1990) The treatment of medulloblastoma. Results of a prospective randomized trial of radiation therapy with and without CCNU, vincristine, and prednisone. J Neurosurg 72:572–582. https://doi.org/10.3171/jns.1990.72.4.0572CrossRefPubMed Evans AE, Jenkin RD, Sposto R, Ortega JA, Wilson CB, Wara W, Ertel IJ, Kramer S, Chang CH, Leikin SL et al (1990) The treatment of medulloblastoma. Results of a prospective randomized trial of radiation therapy with and without CCNU, vincristine, and prednisone. J Neurosurg 72:572–582. https://​doi.​org/​10.​3171/​jns.​1990.​72.​4.​0572CrossRefPubMed

go back to reference Stavrou T, Bromley CM, Nicholson HS, Byrne J, Packer RJ, Goldstein AM, Reaman GH (2001) Prognostic factors and secondary malignancies in childhood medulloblastoma. J Pediatr Hematol Oncol 23:431–436. https://doi.org/10.1097/00043426-200110000-00008CrossRefPubMed Stavrou T, Bromley CM, Nicholson HS, Byrne J, Packer RJ, Goldstein AM, Reaman GH (2001) Prognostic factors and secondary malignancies in childhood medulloblastoma. J Pediatr Hematol Oncol 23:431–436. https://​doi.​org/​10.​1097/​00043426-200110000-00008CrossRefPubMed

go back to reference Grill J, Sainte-Rose C, Jouvet A, Gentet JC, Lejars O, Frappaz D, Doz F, Rialland X, Pichon F, Bertozzi AI, Chastagner P, Couanet D, Habrand JL, Raquin MA, Le Deley MC, Kalifa C (2005) Treatment of medulloblastoma with postoperative chemotherapy alone: an SFOP prospective trial in young children. Lancet Oncol 6:573–580. https://doi.org/10.1016/s1470-2045(05)70252-7CrossRefPubMed Grill J, Sainte-Rose C, Jouvet A, Gentet JC, Lejars O, Frappaz D, Doz F, Rialland X, Pichon F, Bertozzi AI, Chastagner P, Couanet D, Habrand JL, Raquin MA, Le Deley MC, Kalifa C (2005) Treatment of medulloblastoma with postoperative chemotherapy alone: an SFOP prospective trial in young children. Lancet Oncol 6:573–580. https://​doi.​org/​10.​1016/​s1470-2045(05)70252-7CrossRefPubMed

go back to reference Tarbell NJ, Friedman H, Polkinghorn WR, Yock T, Zhou T, Chen Z, Burger P, Barnes P, Kun L (2013) High-risk medulloblastoma: a pediatric oncology group randomized trial of chemotherapy before or after radiation therapy (POG 9031). J Clin Oncol 31:2936–2941. https://doi.org/10.1200/jco.2012.43.9984CrossRefPubMedPubMedCentral Tarbell NJ, Friedman H, Polkinghorn WR, Yock T, Zhou T, Chen Z, Burger P, Barnes P, Kun L (2013) High-risk medulloblastoma: a pediatric oncology group randomized trial of chemotherapy before or after radiation therapy (POG 9031). J Clin Oncol 31:2936–2941. https://​doi.​org/​10.​1200/​jco.​2012.​43.​9984CrossRefPubMedPubMedCentral

go back to reference Gajjar A, Sanford RA, Bhargava R, Heideman R, Walter A, Li Y, Langston JW, Jenkins JJ, Muhlbauer M, Boyett J, Kun LE (1996) Medulloblastoma with brain stem involvement: the impact of gross total resection on outcome. Pediatr Neurosurg 25:182–187. https://doi.org/10.1159/000121121CrossRefPubMed Gajjar A, Sanford RA, Bhargava R, Heideman R, Walter A, Li Y, Langston JW, Jenkins JJ, Muhlbauer M, Boyett J, Kun LE (1996) Medulloblastoma with brain stem involvement: the impact of gross total resection on outcome. Pediatr Neurosurg 25:182–187. https://​doi.​org/​10.​1159/​000121121CrossRefPubMed

go back to reference Pollack IF, Polinko P, Albright AL, Towbin R, Fitz C (1995) Mutism and pseudobulbar symptoms after resection of posterior fossa tumors in children: incidence and pathophysiology. Neurosurgery 37:885–893. https://doi.org/10.1227/00006123-199511000-00006CrossRefPubMed Pollack IF, Polinko P, Albright AL, Towbin R, Fitz C (1995) Mutism and pseudobulbar symptoms after resection of posterior fossa tumors in children: incidence and pathophysiology. Neurosurgery 37:885–893. https://​doi.​org/​10.​1227/​00006123-199511000-00006CrossRefPubMed

go back to reference Albright AL, Sposto R, Holmes E, Zeltzer PM, Finlay JL, Wisoff JH, Berger MS, Packer RJ, Pollack IF (2000) Correlation of neurosurgical subspecialization with outcomes in children with malignant brain tumors. Neurosurgery 47:879–885; discussion 885–877. https://doi.org/10.1097/00006123-200010000-00018 Albright AL, Sposto R, Holmes E, Zeltzer PM, Finlay JL, Wisoff JH, Berger MS, Packer RJ, Pollack IF (2000) Correlation of neurosurgical subspecialization with outcomes in children with malignant brain tumors. Neurosurgery 47:879–885; discussion 885–877. https://​doi.​org/​10.​1097/​00006123-200010000-00018

go back to reference Cochrane DD, Gustavsson B, Poskitt KP, Steinbok P, Kestle JR (1994) The surgical and natural morbidity of aggressive resection for posterior fossa tumors in childhood. Pediatr Neurosurg 20:19–29. https://doi.org/10.1159/000120761CrossRefPubMed Cochrane DD, Gustavsson B, Poskitt KP, Steinbok P, Kestle JR (1994) The surgical and natural morbidity of aggressive resection for posterior fossa tumors in childhood. Pediatr Neurosurg 20:19–29. https://​doi.​org/​10.​1159/​000120761CrossRefPubMed

go back to reference Tamburrini G, Frassanito P, Chieffo D, Massimi L, Caldarelli M, Di Rocco C (2015) Cerebellar mutism. Childs Nerv Syst 31:1841–1851. https://doi.org/10.1007/s00381-015-2803-6CrossRefPubMed Tamburrini G, Frassanito P, Chieffo D, Massimi L, Caldarelli M, Di Rocco C (2015) Cerebellar mutism. Childs Nerv Syst 31:1841–1851. https://​doi.​org/​10.​1007/​s00381-015-2803-6CrossRefPubMed

go back to reference Cobourn K, Marayati F, Tsering D, Ayers O, Myseros JS, Magge SN, Oluigbo CO, Keating RF (2020) Cerebellar mutism syndrome: current approaches to minimize risk for CMS. Childs Nerv Syst 36:1171–1179. https://doi.org/10.1007/s00381-019-04240-xCrossRefPubMed Cobourn K, Marayati F, Tsering D, Ayers O, Myseros JS, Magge SN, Oluigbo CO, Keating RF (2020) Cerebellar mutism syndrome: current approaches to minimize risk for CMS. Childs Nerv Syst 36:1171–1179. https://​doi.​org/​10.​1007/​s00381-019-04240-xCrossRefPubMed

go back to reference Robertson PL, Muraszko KM, Holmes EJ, Sposto R, Packer RJ, Gajjar A, Dias MS, Allen JC (2006) Incidence and severity of postoperative cerebellar mutism syndrome in children with medulloblastoma: a prospective study by the Children’s Oncology Group. J Neurosurg 105:444–451. https://doi.org/10.3171/ped.2006.105.6.444CrossRefPubMed Robertson PL, Muraszko KM, Holmes EJ, Sposto R, Packer RJ, Gajjar A, Dias MS, Allen JC (2006) Incidence and severity of postoperative cerebellar mutism syndrome in children with medulloblastoma: a prospective study by the Children’s Oncology Group. J Neurosurg 105:444–451. https://​doi.​org/​10.​3171/​ped.​2006.​105.​6.​444CrossRefPubMed

go back to reference Levisohn L, Cronin-Golomb A, Schmahmann JD (2000) Neuropsychological consequences of cerebellar tumour resection in children: cerebellar cognitive affective syndrome in a paediatric population. Brain 123(Pt 5):1041–1050. https://doi.org/10.1093/brain/123.5.1041CrossRefPubMed Levisohn L, Cronin-Golomb A, Schmahmann JD (2000) Neuropsychological consequences of cerebellar tumour resection in children: cerebellar cognitive affective syndrome in a paediatric population. Brain 123(Pt 5):1041–1050. https://​doi.​org/​10.​1093/​brain/​123.​5.​1041CrossRefPubMed

go back to reference Korah MP, Esiashvili N, Mazewski CM, Hudgins RJ, Tighiouart M, Janss AJ, Schwaibold FP, Crocker IR, Curran WJ Jr, Marcus RB Jr (2010) Incidence, risks, and sequelae of posterior fossa syndrome in pediatric medulloblastoma. Int J Radiat Oncol Biol Phys 77:106–112. https://doi.org/10.1016/j.ijrobp.2009.04.058CrossRefPubMed Korah MP, Esiashvili N, Mazewski CM, Hudgins RJ, Tighiouart M, Janss AJ, Schwaibold FP, Crocker IR, Curran WJ Jr, Marcus RB Jr (2010) Incidence, risks, and sequelae of posterior fossa syndrome in pediatric medulloblastoma. Int J Radiat Oncol Biol Phys 77:106–112. https://​doi.​org/​10.​1016/​j.​ijrobp.​2009.​04.​058CrossRefPubMed

go back to reference McAfee SS, Zhang S, Zou P, Conklin HM, Raches D, Robinson G, Gajjar A, Khan R, Klimo P, Patay Z, Scoggins MA (2023) Fastigial nuclei surgical damage and focal midbrain disruption implicate PAG survival circuits in cerebellar mutism syndrome. Neuro Oncol 25:375–385. https://doi.org/10.1093/neuonc/noac168CrossRefPubMed McAfee SS, Zhang S, Zou P, Conklin HM, Raches D, Robinson G, Gajjar A, Khan R, Klimo P, Patay Z, Scoggins MA (2023) Fastigial nuclei surgical damage and focal midbrain disruption implicate PAG survival circuits in cerebellar mutism syndrome. Neuro Oncol 25:375–385. https://​doi.​org/​10.​1093/​neuonc/​noac168CrossRefPubMed

go back to reference Law N, Greenberg M, Bouffet E, Taylor MD, Laughlin S, Strother D, Fryer C, McConnell D, Hukin J, Kaise C, Wang F, Mabbott DJ (2012) Clinical and neuroanatomical predictors of cerebellar mutism syndrome. Neuro Oncol 14:1294–1303. https://doi.org/10.1093/neuonc/nos160CrossRefPubMedPubMedCentral Law N, Greenberg M, Bouffet E, Taylor MD, Laughlin S, Strother D, Fryer C, McConnell D, Hukin J, Kaise C, Wang F, Mabbott DJ (2012) Clinical and neuroanatomical predictors of cerebellar mutism syndrome. Neuro Oncol 14:1294–1303. https://​doi.​org/​10.​1093/​neuonc/​nos160CrossRefPubMedPubMedCentral

go back to reference Grill J, Viguier D, Kieffer V, Bulteau C, Sainte-Rose C, Hartmann O, Kalifa C, Dellatolas G (2004) Critical risk factors for intellectual impairment in children with posterior fossa tumors: the role of cerebellar damage. J Neurosurg 101:152–158. https://doi.org/10.3171/ped.2004.101.2.0152CrossRefPubMed Grill J, Viguier D, Kieffer V, Bulteau C, Sainte-Rose C, Hartmann O, Kalifa C, Dellatolas G (2004) Critical risk factors for intellectual impairment in children with posterior fossa tumors: the role of cerebellar damage. J Neurosurg 101:152–158. https://​doi.​org/​10.​3171/​ped.​2004.​101.​2.​0152CrossRefPubMed

go back to reference Ramaswamy V, Northcott PA, Taylor MD (2011) FISH and chips: the recipe for improved prognostication and outcomes for children with medulloblastoma. Cancer Genet 204:577–588. https://doi.org/10.1016/j.cancergen.2011.11.001CrossRefPubMed Ramaswamy V, Northcott PA, Taylor MD (2011) FISH and chips: the recipe for improved prognostication and outcomes for children with medulloblastoma. Cancer Genet 204:577–588. https://​doi.​org/​10.​1016/​j.​cancergen.​2011.​11.​001CrossRefPubMed

go back to reference Fangusaro J, Bandopadhayay P (2021) Advances in the classification and treatment of pediatric brain tumors. Curr Opin Pediatr 33:26–32. https://doi.org/10.1097/mop.0000000000000975CrossRefPubMed Fangusaro J, Bandopadhayay P (2021) Advances in the classification and treatment of pediatric brain tumors. Curr Opin Pediatr 33:26–32. https://​doi.​org/​10.​1097/​mop.​0000000000000975​CrossRefPubMed

go back to reference Lazow MA, Palmer JD, Fouladi M, Salloum R (2022) Medulloblastoma in the modern era: review of contemporary trials, molecular advances, and updates in management. Neurotherapeutics 19:1733–1751. https://doi.org/10.1007/s13311-022-01273-0CrossRefPubMedPubMedCentral Lazow MA, Palmer JD, Fouladi M, Salloum R (2022) Medulloblastoma in the modern era: review of contemporary trials, molecular advances, and updates in management. Neurotherapeutics 19:1733–1751. https://​doi.​org/​10.​1007/​s13311-022-01273-0CrossRefPubMedPubMedCentral

go back to reference Sutton LN, Phillips PC, Molloy PT (1996) Surgical management of medulloblastoma. J Neurooncol 29:9–21. https://doi.org/10.1007/bf00165514CrossRefPubMed Sutton LN, Phillips PC, Molloy PT (1996) Surgical management of medulloblastoma. J Neurooncol 29:9–21. https://​doi.​org/​10.​1007/​bf00165514CrossRefPubMed

go back to reference Choudhri AF, Klimo P Jr, Auschwitz TS, Whitehead MT, Boop FA (2014) 3T intraoperative MRI for management of pediatric CNS neoplasms. AJNR Am J Neuroradiol 35:2382–2387. https://doi.org/10.3174/ajnr.A4040CrossRefPubMedPubMedCentral Choudhri AF, Klimo P Jr, Auschwitz TS, Whitehead MT, Boop FA (2014) 3T intraoperative MRI for management of pediatric CNS neoplasms. AJNR Am J Neuroradiol 35:2382–2387. https://​doi.​org/​10.​3174/​ajnr.​A4040CrossRefPubMedPubMedCentral

go back to reference Choudhri AF, Siddiqui A, Klimo P Jr (2016) Pediatric cerebellar tumors: emerging imaging techniques and advances in understanding of genetic features. Magn Reson Imaging Clin N Am 24:811–821. https://doi.org/10.1016/j.mric.2016.07.006CrossRefPubMed Choudhri AF, Siddiqui A, Klimo P Jr (2016) Pediatric cerebellar tumors: emerging imaging techniques and advances in understanding of genetic features. Magn Reson Imaging Clin N Am 24:811–821. https://​doi.​org/​10.​1016/​j.​mric.​2016.​07.​006CrossRefPubMed

go back to reference Rogers CM, Jones PS, Weinberg JS (2021) Intraoperative MRI for brain tumors. J Neurooncol 151:479–490. https://doi.org/10.1007/s11060-020-03667-6CrossRefPubMed Rogers CM, Jones PS, Weinberg JS (2021) Intraoperative MRI for brain tumors. J Neurooncol 151:479–490. https://​doi.​org/​10.​1007/​s11060-020-03667-6CrossRefPubMed

go back to reference Laochamroonvorapongse D, Theard MA, Yahanda AT, Chicoine MR (2021) Intraoperative MRI for adult and pediatric neurosurgery. Anesthesiol Clin 39:211–225. https://doi.org/10.1016/j.anclin.2020.11.010CrossRefPubMed Laochamroonvorapongse D, Theard MA, Yahanda AT, Chicoine MR (2021) Intraoperative MRI for adult and pediatric neurosurgery. Anesthesiol Clin 39:211–225. https://​doi.​org/​10.​1016/​j.​anclin.​2020.​11.​010CrossRefPubMed

go back to reference Lam CH, Hall WA, Truwit CL, Liu H (2001) Intra-operative MRI-guided approaches to the pediatric posterior fossa tumors. Pediatr Neurosurg 34:295–300. https://doi.org/10.1159/000056041CrossRefPubMed Lam CH, Hall WA, Truwit CL, Liu H (2001) Intra-operative MRI-guided approaches to the pediatric posterior fossa tumors. Pediatr Neurosurg 34:295–300. https://​doi.​org/​10.​1159/​000056041CrossRefPubMed

go back to reference Patel P, Wallace D, Boop FA, Vaughn B, Robinson GW, Gajjar A, Klimo P (2019) Reoperation for medulloblastoma prior to adjuvant therapy. Neurosurgery 84:1050–1058. https://doi.org/10.1093/neuros/nyy095CrossRefPubMed Patel P, Wallace D, Boop FA, Vaughn B, Robinson GW, Gajjar A, Klimo P (2019) Reoperation for medulloblastoma prior to adjuvant therapy. Neurosurgery 84:1050–1058. https://​doi.​org/​10.​1093/​neuros/​nyy095CrossRefPubMed

go back to reference Khan RB, Sanford RA, Kun LE, Thompson SJ (2001) Morbidity of second-look surgery in pediatric central nervous system tumors. Pediatr Neurosurg 35:225–229. https://doi.org/10.1159/000050426CrossRefPubMed Khan RB, Sanford RA, Kun LE, Thompson SJ (2001) Morbidity of second-look surgery in pediatric central nervous system tumors. Pediatr Neurosurg 35:225–229. https://​doi.​org/​10.​1159/​000050426CrossRefPubMed